s.radich

TL2 · Medellín

Contributes reviews on supplier material. Based in Medellín.

Joined 1 September 2025 · last posted 1d

84Posts here

1Topics

2Solutions

1.2kLikes received

1.4kLikes given

22Badges

233Days visited

5.3kPosts read

Recent activity

Full stream

Travelling with an injectable: documentation and practicalities Replied, post #43 · Access › International · 27 Jul 2026 · 25 likes Where a jurisdiction has published guidance for clinicians, that document usually answers the practical questions better than any consumer-facing page. Noting that the…
Journal club: STEP 1 and the treatment-policy estimand Replied, post #3 · Evidence › Journal club · 18 Jul 2026 · 19 likes I read the opening post twice before replying, because I had assumed the opposite. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the…
Alcohol: what is documented and what is folklore Replied, post #119 · Practice › Interactions · 18 Jul 2026 · 0 likes This follows post #116 rather than contradicting it. A supplement is a drug for interaction purposes, and the fact that it is sold without a prescription tells you…
I joined for one answer and stayed for a year — what changed my mind Replied, post #90 · Start Here › Welcome · 17 Jul 2026 · 32 likes Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They answer most of the questions a new member has and they save…
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #105 · Evidence › Preprints · 13 Jul 2026 · 0 likes On post #102 — agreed on the reasoning, with one qualification. Author track record is a weak signal and it is a signal. A group that has published carefully for years…
What to bring: records that a clinician can actually use — a second dataset Started this topic · Clinical › Prescriber conversations · 1 Jul 2026 · 38 likes What to bring: records that a clinician can actually use — a second dataset I have a specific reason for asking rather than idle curiosity, and the context is below. A…
Revisiting: Protein density versus volume when you cannot eat much Replied, post #21 · Nutrition & Training › Protein & intake · 30 Jun 2026 · 0 likes The mechanism is not mysterious. Substantial energy restriction with inadequate protein and no resistance stimulus loses lean tissue as well as fat.
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #54 · Evidence › Journal club · 23 Jun 2026 · 0 likes Adding a null result on SURMOUNT-OSA. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
Why the timeline is on the right and not the left — what changed since Replied, post #59 · Meta › Site feedback · 21 Jun 2026 · 0 likes Moderation decisions: if you disagree with a moderation decision, raising it here gives it visibility. Staff will reconsider if you make a substantive case. Not…
Racemisation and why it is invisible to a mass measurement Replied, post #62 · Analytics › Impurities & related substances · 12 Jun 2026 · 0 likes Coming back to post #61, because the follow-up matters more than the original answer. The bit of racemisation that nobody enjoys is that the answer changes depending on…
Why fasting instructions for oral semaglutide are not optional advice Replied, post #38 · Compounds › Oral incretins · 12 Jun 2026 · 3 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #45 · Analytics › Home & field testing · 12 Jun 2026 · 10 likes Picking up post #42: that is the part I would want checked first. Careful with the language on Lateral-flow and colorimetric approaches. "Not detected" and "not…